CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...

Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on ...

Bruker (BRKR) and 10x Genomics (TXG) have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross-license agreements between the two ...

Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at $9.49, but there ...

Complete tasks in the background (including yolo / auto-accept mode!) Manage instances and tasks in one terminal window Review changes before applying them, checkout changes before pushing them Each ...

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate ...

PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will ...

Cells were collected 14 days post transduction and processed per manufacturer’s instructions using the 10x Chromium Next GEM Single Cell ... We would like to thank the Fred Hutch Genomics Shared ...